Prices as of 2025-12-04 10:01:23 ET
Ticker Appearances
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Your Weekly Roadmap
Stocks Pull Back Heading into Next CPI Release
Good evening, Fundstrat Head of Research Tom Lee has repeatedly told readers that we are in a “buy the dip” regime, and this week the...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Daily Technical Strategy
Medical Devices breakout should give Healthcare a further boost
I WILL NOT BE PUBLISHING FRIDAY, 4/21 DUE TO TRAVEL PLANS. THANK YOU FOR YOUR UNDERSTANDING. No evidence of any change of trend,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Your Weekly Roadmap
Stocks Pull Back Heading into Next CPI Release
Good evening, Fundstrat Head of Research Tom Lee has repeatedly told readers that we are in a “buy the dip” regime, and this week the...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Daily Technical Strategy
Medical Devices breakout should give Healthcare a further boost
I WILL NOT BE PUBLISHING FRIDAY, 4/21 DUE TO TRAVEL PLANS. THANK YOU FOR YOUR UNDERSTANDING. No evidence of any change of trend,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Daily Technical Strategy
Biotechnology looks like what to favor in a deteriorating Healthcare sector
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Articles Read 2/2
🎁 Unlock 1 extra article by joining our Community!
You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.
Already have an account? Sign In 0a50f6-761889-ba31af-78609b-7fcd0a
Already have an account? Sign In 0a50f6-761889-ba31af-78609b-7fcd0a
